Optimos Cystotome— 510(k) K223256

Substantially Equivalent

Taewoong Medical Co., Ltd.

FDA 510(k) clearance K223256 for Optimos Cystotome, Substantially Equivalent on 2023-04-05. Applicant: Taewoong Medical Co., Ltd..

Clearance details

Applicant: Taewoong Medical Co., Ltd.
Product code: Code KNS
Advisory panel: Gastroenterology, Urology
Date received: 2022-10-21
Decision date: 2023-04-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Gimpo-Si, KR

Download summary PDF View on FDA.gov ↗

Adverse events under product code KNS

product code KNS

Death: 44
Injury: 2,361
Malfunction: 4,771
Total: 7,176

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.